Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis-Reference-Cited by-同舟云学术

Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis

Published:2014-06 Issue:6 Volume:42 Page:612-620
ISSN:0196-6553
Container-title:American Journal of Infection Control
language:en
Short-container-title:American Journal of Infection Control

Author:

Bogan Christopher,Kaye Keith S.,Chopra Teena,Hayakawa Kayoko,Pogue Jason M.,Lephart Paul R.,Bheemreddy Suchitha,Lazarovitch Tsilia,Zaidenstein Ronit,Perez Federico,Bonomo Robert A.,Marchaim Dror

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,Epidemiology

Reference46 articles.

1. Has the era of untreatable infections arrived?;Livermore;J Antimicrob Chemother,2009

2. Management of gram-positive bacterial infections in patients with cancer;Kosmidis;Leuk Lymphoma,2012

3. Hospital-acquired infections due to gram-negative bacteria;Peleg;N Engl J Med,2010

4. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America;Boucher;Clin Infect Dis,2009

5. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy;Paterson;Clin Infect Dis,2008

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

2. Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer β-lactam or β-lactam/β-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimen;Journal of Antimicrobial Chemotherapy;2023-11-14

3. Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review;Antibiotics;2023-07-31

4. High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases;Antimicrobial Resistance & Infection Control;2023-07-08

5. Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year Retrospective Study;Infection and Drug Resistance;2022-12